Northbrook, IL (September 8, 2020) – Paradise Genomics announced that it has advanced the development of their whole blood-based assay for gastric cancer by translating a gene expression profile associated with the disease into a high-throughput, cost effective RT-PCR test. The company is currently evaluating strategic partners to help bring this early detection molecular diagnostic to the clinic. Read More >